Stack Labby Revive One
Browse/Peptide
Peptide

CJC-1295

01 / OVERVIEW

What this compound does

WHAT IT DOES

CJC-1295 tells the pituitary to release more growth hormone, and the DAC version keeps working for days. Often paired with ipamorelin.

KEY BENEFITS
Raises GH and IGF-1
Long-acting (DAC form)
Synergistic with ghrelin-receptor peptides
BEST FOR
  • • Adults exploring GH-axis recovery support
WHAT TO EXPECT

Commonly stacked with ipamorelin. Not FDA-approved for these uses.

WHO SHOULD AVOID THIS
  • • People with active cancer
  • • Diabetics without supervision
  • • Pregnant or breastfeeding people
MYTHS & FACTS
Myth:
Fact:
Myth:
Fact:
At a glance
Typical dose
1-2 mg/week (DAC) or 100 mcg 1-3x/day (no-DAC) research protocols
Evidence
—
Studies indexed1
How it's made

GHRH-analog peptide synthesised, HPLC-purified, lyophilised.

03 / DOSAGE

How much, when

MAINTENANCE

1-2 mg/week (DAC) or 100 mcg 1-3x/day (no-DAC) research protocols

subcutaneous

TIMING

CJC-1295 — Bedtime dose

Take on empty stomach

02 / EVIDENCE

Peer-reviewed studies

  • PMID: 16352683

    Sustained GH/IGF-1 elevation

    A single-dose human study showed CJC-1295 increased GH and IGF-1 for up to ~1-2 weeks with the DAC form.

    B
  • PMID 16352683 · 2006human

    Prolonged stimulation of GH and IGF-1 by CJC-1295

    Sustained GH/IGF-1 rise

    B
04 / INTERACTIONS

Medicine interactions

  • Insulin / antidiabetics· antidiabetic

    GH/IGF-1 elevation can alter glucose control.

    → Monitor glucose under clinician care.

    MODERATE

This page is a reference summary, not a prescription. Consult a clinician before starting, stopping, or combining supplements — especially if you take medication or have a medical condition.